Study Stopped
Unable to recruit sufficient participants
Validation of Nexfin Cardiac Output in Elderly Patients With Hip Fracture
Validation of the Nexfin Non-invasive Cardiac Output Monitor in Patients Undergoing Hip Fracture Repair
2 other identifiers
observational
6
1 country
2
Brief Summary
Measurement of how much blood the heart pumps may be useful in guiding how much intravenous fluid to give patients during surgery. The current monitors either require special drips (arterial and/or central lines) or a probe inserted into the oesophagus (food pipe) which may limit their use. Newer monitors are available which are completely non-invasive and seem to work well in younger patients. Patients with hip fracture are elderly and frail. The investigators wish to see whether the newer non-invasive monitor works well enough compared to the current monitors in this group of patients. If it does this may allow more of these patients to be monitored in this way.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2013
Shorter than P25 for all trials
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 14, 2011
CompletedFirst Posted
Study publicly available on registry
November 18, 2011
CompletedStudy Start
First participant enrolled
January 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2013
CompletedDecember 4, 2014
December 1, 2014
9 months
October 14, 2011
December 3, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bias and limits of agreement of Nexfin recorded cardiac output compared with LiDCOplus
Analysis of agreement between Nexfin cardiac output and the calibrated cardiac output measured by LiDCOplus
During anaesthesia period of surgery - measurements will be complete within 30 minutes of starting anaesthesia
Secondary Outcomes (3)
Bias and limits of agreement for change in cardiac output measured by Nexfin compared with LiDCO
During anaesthesia period of surgery - measurements will be complete within 30 minutes of starting anaesthesia
Utility of Nexfin monitor
Intra-operative - average duration about 1 hour
Adverse events associated with Nexfin monitor
Intra-operative - average duration about one hour
Eligibility Criteria
Elderly patients undergoing surgical repair of hip fracture
You may qualify if:
- Aged over 80
- Able to give their own informed consent
You may not qualify if:
- Severe valvular heart disease
- Taking lithium
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Nottingham University Hospitals
Nottingham, Notts, NG7 2UH, United Kingdom
Brighton and Sussex University Hospitals
Brighton, Sussex, BN2 5BE, United Kingdom
Related Publications (1)
Wiles MD, Whiteley WJ, Moran CG, Moppett IK. The use of LiDCO based fluid management in patients undergoing hip fracture surgery under spinal anaesthesia: neck of femur optimisation therapy - targeted stroke volume (NOTTS): study protocol for a randomized controlled trial. Trials. 2011 Sep 28;12:213. doi: 10.1186/1745-6215-12-213.
PMID: 21955538BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Iain K Moppett, DM FRCA MRCP
University of Nottingham
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 14, 2011
First Posted
November 18, 2011
Study Start
January 1, 2013
Primary Completion
October 1, 2013
Study Completion
October 1, 2013
Last Updated
December 4, 2014
Record last verified: 2014-12